Table 1 Demographic profile and baseline characteristics of the study participants
Total (n = 200) | Male (n = 113) | Female (n = 87) | ||
|---|---|---|---|---|
Age (years) | Mean (SD) | 60.89 ± 10.08 | 59.03 ± 9.99 | 63.31 ± 9.73 |
Weight (kg) | Mean (SD) | 73.77 ± 11.70 | 78.23 ± 11.39 | 67.97 ± 9.37 |
Height (cm) | Mean (SD) | 162.40 ± 8.92 | 168.11 ± 6.40 | 154.98 ± 5.67 |
BMI (kg/m2) | Mean (SD) | 28.05 ± 2.96 | 27.90 ± 2.65 | 28.26 ± 3.33 |
BMI (kg/m2) | Lower quartile | 26.40 | 26.15 | 26.50 |
Median | 27.88 | 27.64 | 28.40 | |
Upper quartile | 30.11 | 29.73 | 30.46 | |
HbA1c (%) | Mean (SD) | 7.75 ± 1.11 | 7.77 ± 1.13 | 7.74 ± 1.10 |
Glucose (mg/dL) | Mean (SD) | 158.41 ± 45.93 | 131.77 ± 51.36 | 154.05 ± 37.58 |
GFR (mL/min/1.73 m2) | Mean (SD) | 89.60 ± 15.56 | 89.54 ± 16.12 | 89.67 ± 14.89 |
Smoking status | Current smoker | 42 (21.0%) | 39 (34.5%) | 3 (3.4%) |
Alcohol consumption | Heavy drinker | 65 (32.5%) | 55 (48.7%) | 10 (11.5%) |
Exercise | Regular exercise | 67 (33.5%) | 44 (38.9%) | 23 (26.4%) |
Comorbidity | Hypertension | 151 (75.5%) | 88 (77.9%) | 63 (72.4%) |
Dyslipidemia | 183 (91.5%) | 101 (89.4%) | 82 (94.3%) | |
CVD | 7 (3.5%) | 7 (6.2%) | 0 (0%) | |
Co-DM medication | Metformin | 157 (78.5%) | 92 (81.4%) | 65 (74.7%) |
Sulfonylurea | 80 (40.0%) | 43 (38.1%) | 37 (42.5%) |